Sulfonylureas are medications that force the pancreas to make more insulin. As a result, they are very effective at controlling blood sugar, but are also more likely to cause dangerously low blood sugar (hypoglycemia). These medications include:
Metformin (Fortamet®, Glucophage®, Glucophage XR®, Glumetza®, or Riomet®) is the only biguanide medication currently available. Metformin works by helping the body use its natural insulin better. It also decreases sugar (glucose) production by the liver, and decreases sugar absorption from the diet.
Meglitinides are similar to sulfonylureas, in that they force the pancreas to produce more insulin. However, they are short-acting and are less likely to cause dangerously low blood sugar. They are usually taken before every meal. Meglitinides include:
These diabetes drugs prevent the breakdown of sugar and carbohydrates in the digestive tract, slowing their absorption. These medications are used to decrease blood sugar levels after meals. Types of this diabetes medication include:
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Avandia [package insert]. Research Triangle Park, NC: GlaxoSmithKline;2011 February.
Food and Drug Administration, Center for Drug Evaluation and Research. Avandia (rosiglitazone): REMS - risk of cardiovascular events (9/23/2010). FDA Web site. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm226994.htm. Accessed October 1, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click